Elekta and GE Healthcare collaborate to expand access to precision radiation therapy solutions
SINGAPORE,April 5,2022 -- Elekta (EKTA-B.ST) and GE Healthcare announced today that they have signed a global commercial collaboration agreement in the field of radiation oncology,enabling them to provide hospitals a complete offering across imaging and therapy for cancer patients requiring radiation therapy.
As hospitals increasingly seek flexible and interoperable simulation and guidance technology,Elekta and GE Healthcare aim to meet the major need for radiotherapy solutions across both developed and developing markets.
As many as 50–60 percent of all cancer patients require radiation therapy[1] which requires high quality imaging and sophisticated delivery equipment and software to precisely target tumors while sparing healthy tissue. Precision imaging is fundamental to determining the size,shape and characteristics of tumors and differentiating between healthy tissues. Delivering the most appropriate dose requiresadvanced patient positioning,motion management technologies and state-of-the-art techniques such as VMAT[2] or SBRT[3]. Combining GE Healthcare's imaging solutions with Elekta's radiation therapy solutions will result in an even more compelling offering for hospitals.
Elekta CEO,Gustaf Salford,said: "We are driven by our customers' preferences and their need for comprehensive solutions in effective,efficient and safe cancer care.Therefore,we're excited about this collaboration with GE Healthcare. We have many mutual customers who see clear synergies and advantages with our respective,strong product portfolios. This will allow us to jointly promote the most optimal solutions for each cancer center's needs. Elekta strives to assure that customers can create seamless ecosystems that facilitate efficient end-to-end cancer care."
"Access to radiation therapy is a significant challenge in several parts of the globe. We are pleased that this collaboration is a step in the right direction to make more comprehensive solutions more readily available," said Jan Makela,President & CEO GE Healthcare Imaging. "Cancer care can only be improved if players in the field work together and this is one of several partnerships that we are pursuing,for the benefit of caregivers and patients,as we build out our Oncology offerings."
GE Healthcare and Elekta will continue to offer their own solutions using standard interfaces and facilitate interoperability with any vendor's systems.
The agreement is non-exclusive,meaning each party can continue to cooperate with other partners. Separately,both companies are eager to explore opportunities to improve interoperability and streamline workflows in radiation oncology.
[1]Atun et al,Expanding global access to radiotherapy,The Lancet Oncol 2015 Sep; 16(10): 1153-86 https://pubmed.ncbi.nlm.nih.gov/26419354/
[2]Volumetric Modulated Arc Therapy – a novel radiation therapy technique that delivers the radiation dose continuously as the treatment machine rotates
[3]Stereotactic body radiotherapy,which gives radiotherapy from many different angles around the body,with the beams meeting at the tumor. https://www.cancerresearchuk.org/about-cancer/cancer-in-general/treatment/radiotherapy/external/types/stereotactic-body-radiotherapy-sbrt
About Elekta
As a leader in precision radiation therapy,Elekta is committed to ensuring every patient has access to the best cancer care possible. We openly collaborate with customers to advance sustainable,outcome-driven and cost-efficient solutions to meet evolving patient needs,improve lives and bring hope to everyone dealing with cancer. To us,it's personal,and our global team of 4,700 employees combine passion,science,and imagination to profoundly change cancer care. We don't just build technology,we build hope. Elekta is headquartered in Stockholm,Sweden,with offices in more than 120 countries and listed on Nasdaq Stockholm. For more information,visit elekta.com or follow @Elekta on Twitter.
About GE Healthcare
GE Healthcare is the $17.7 billion healthcare business of GE (NYSE: GE). As a leading global medical technology,pharmaceutical diagnostics and digital solutions innovator,GE Healthcare enables clinicians to make faster,more informed decisions through intelligent devices,data analytics,applications and services,supported by its Edison intelligence platform. With over 100 years of healthcare industry experience and around 47,000 employees globally,the company operates at the center of an ecosystem working toward precision health,digitizing healthcare,helping drive productivity and improve outcomes for patients,providers,health systems and researchers around the world.
Follow us onFacebook,LinkedIn,Twitter,InstagramandInsightsfor the latest news,or visit our websitewww.gehealthcare.comfor more information.
